Skip to main content
Fig. 2 | BMC Public Health

Fig. 2

From: The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea

Fig. 2

Kaplan-Meier curves for the duration of prescribing NOACs in health care institutions. Note: a types of institutions, b locations of institutions. Duration starts from the date of the reimbursement decision on October 1, 2010. Durations 29.39 and 61.92 present the date of the extension of reimbursement with a letter of opinion and the withdrawal of the need for a letter of opinion, respectively

Back to article page
\